COM:NEUROCRINE
Neurocrine Biosciences
- Stock
locale
United Statesmarket
STOCKSindustry
Pharmaceuticalswebsite
www.neurocrine.comipo date
May 23, 1996
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatme...Show More